AAFP President to Primary Care Clinicians: On Vaccines—Listen, Reassure, Advocate
The COVID-19 pandemic derailed routine immunizations and triggered a flood of vaccine misinformation beyond the COVID shot. Here, 3 ways to move forward.
Long COVID: Hyperbaric Oxygen Therapy Offers Hope for Understanding and Treating Symptoms
Hyperbaric oxygen therapy in a randomized placebo-controlled trial resulted in improved global cognitive function, energy, sleep, and pain interference in long COVID patients.
Daily Dose: Obesity and Risk of Frailty
Your daily dose of clinical news you may have missed.
Evusheld EUA Withdrawn, FDA Recommends Other Therapies
The FDA wants clinicians to avoid using the neutralizing antibody as it appears to be less effective against newer circulating strains of the SARS-CoV-2 virus.
Top 10 Diabetes Diets for 2023
The DASH diet, Mediterranean diet, and Flexitarian diet top the list of 10 best diets for persons with diabetes as ranked by US News and World Report.
Study: Bariatric Surgery Linked to Significant Decrease in Mortality at 40-year Follow-up
A pivotal study with 40-year follow-up of post-bariatric surgery patients reinforces long-term benefits of the procedures on all-cause and cause-specific mortality.
How to Spot and Approach a Colleague in Distress
Mental health issues among health care professionals have always been normal; now that we can acknowledge them, we must, says a family physician and wellness advocate.
Obesity in Adulthood Associated with Increased Risk of Frailty Later in Life
Results from longitudinal prospective cohort study underscore the importance of monitoring patients’ weight throughout adulthood to reduce the risk of frailty.
It's Vaccination Catch-up Time for Kids: An APB from AAFP President Iroku-Malize
AAFP president Tochi Iroku-Malize, MD, MPH, MBA, urges gentle but persistent efforts among all clinicians to get school-aged children back on vaccination track.
The COVID-19 Vaccine Halo Effect: Survey Highlights
The Kaiser Family Foundation survey found a 10% drop in the proportion of adults who say MMR vaccination should be required for school attendance, and other "halo" effects.
Daily Dose: Semaglutide 2.4 mg and Long-term Weight Loss
CDC Releases First Estimates of Bivalent mRNA COVID-19 Booster Effectiveness against XBB/XBB.1.5
Preliminary estimates showed relative bivalent booster dose vaccine effectiveness against XBB/XBB.1.5 for at least the first 3 months after vaccination.
Dementia Risk in Older Women Reduced with More Vigorous Physical Activity, More Daily Steps
Accelerometer-measured physical activity and steps were associated with as much as a 60% lower risk of Alzheimer's disease and related dementias in a new study.
Declining Kindergarten Vaccination Rate Leaves 250k Children Unprotected: AAFP President's Perspective
Tochi Iroku-Malize, MD, MPH, MBA, converts the 93% immunization rate for US kindergarteners into raw numbers of children now vulnerable to vaccine-preventable disease.
Daily Dose: Improved Glycemic Control and NAFLD in Type 2 Diabetes
Cannabis Legalization and Prenatal Marijuana Use: Pregnant Women Describe Impact
New research offers insight into how women who use cannabis during pregnancy perceive the impacts of cannabis legalization.
Semaglutide 2.4 mg Sustains Long-term Weight Loss by Reducing Cravings, Appetite: New Analysis
Sustained weight loss with semaglutide 2.4 mg is a result of the drug's effects on control of eating, including reduced cravings and hunger and increased satiety, study authors write.
Daily Dose: HDL-C and Fracture Risk in Older Adults
FDA Approves SGLT2 Inhibitor Bexagliflozin to Treat Type 2 Diabetes in Adults
Bexagliflozin significantly improved glycemic control in adults when used as monotherapy, in combination with metformin, or when added to several SOC regimens.
Improved HbA1c in Adults with T2D Had Beneficial Impact on NAFLD, According to New Study
Adults with T2D may be able to reduce their liver fat and improve their liver fibrosis stage with reductions in HbA1c, according to findings from a retrospective analysis.
